Michael S. Pulia

Michael S. Pulia

Auto-generated profile, based on publicly available information

Michael S. Pulia

BerbeeWalsh Department of Emergency Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin; Department of Industrial and Systems Engineering, University of Wisconsin-Madison School of Engineering, Madison, Wisconsin

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Emergency Medicine Clinics of North America
Verified
Journal Article
Closed access
MPMichael Pulia
Michael Pulia
RRRobert Redwood
Robert Redwood
LMLarissa May
Larissa May

1 November 2021 in Applied Ergonomics
Verified
Journal Article
Closed access
MSMegan E. Salwei
Megan E. Salwei
PCPascale Carayon
Pascale Carayon
PHPeter L.T. Hoonakker
Peter L.T. Hoonakker
AHAnn Schoofs Hundt
Ann Schoofs Hundt
DWDouglas Wiegmann
Douglas Wiegmann
BPBrian W. Patterson
Brian W. Patterson

14 May 2020 in Annals of Medicine
Verified
Journal Article
Open access
MPMichael S. Pulia
Michael S. Pulia
TOTerrence P. O’bRien
Terrence P. O’bRien
PHPeter C. Hou
Peter C. Hou
ASAndrew Schuman
Andrew Schuman
RSRobert Sambursky
Robert Sambursky
Coronavirus disease 2019 (COVID-19), caused by novel enveloped single stranded RNA coronavirus (SARS-CoV-2), is responsible for an ongoing global pandemic. While other countries deployed widespread testing as an early mitigation strategy, the U.S. experienced delays in development and deployment of organism identification assays. As such, there is uncertainty surrounding disease burden and community spread, severely hampering containment efforts. COVID-19 illuminates the need for a tiered diagnostic approach to rapidly identify clinically significant infections and reduce disease spread. Without the ability to efficiently screen patients, hospitals are overwhelmed, potentially delaying treatment for other emergencies. A multi-tiered, diagnostic strategy incorporating a rapid host immune response assay as a screening test; molecular confirmatory testing and rapid IgM/IgG testing to assess benefit from quarantine/further testing and provide information on population exposure/herd immunity would efficiently evaluate potential COVID-19 patients. Triaging patients within minutes with a fingerstick rather than hours/days after an invasive swab is critical to pandemic response as reliance on the existing strategy is limited by assay accuracy, time to results, and testing capacity. Early screening and triage is achievable from the outset of a pandemic with point-of-care host immune response testing which will improve response time to clinical and public health actions.

14 June 2018 in Antimicrobial Resistance & Infection Control
Verified
Journal Article
Open access
PDF file
MPMichael Pulia
Michael Pulia
MKMichael Kern
Michael Kern
RSRebecca Schwei
Rebecca Schwei
MSManish N. Shah
Manish N. Shah
ESEmmanuel Sampene
Emmanuel Sampene
CCChristopher J. Crnich
Christopher J. Crnich
Background: The pervasive, often inappropriate, use of antibiotics in healthcare settings has been identified as a major public health threat due to the resultant widespread emergence of antibiotic resistant bacteria. In nursing homes (NH), as many as two-thirds of residents receive antibiotics each year and up to 75% of these are estimated to be inappropriate. The objective of this study was to characterize antibiotic therapy for NH residents and compare appropriateness based on setting of prescription initiation. Methods: This was a retrospective, cross-sectional multi-center study that occurred in five NHs in southern Wisconsin between January 2013 and September 2014. All NH residents with an antibiotic prescribing events for suspected lower respiratory tract infections (LRTI), skin and soft tissue infections (SSTI), and urinary tract infections (UTI), initiated in-facility, from an emergency department (ED), or an outpatient clinic were included in this sample. We assessed appropriateness of antibiotic prescribing using the Loeb criteria based on documentation available in the NH medical record or transfer documents. We compared appropriateness by setting and infection type using the Chi-square test and estimated associations of demographic and clinical variables with inappropriate antibiotic prescribing using logistic regression. Results: Among 735 antibiotic starts, 640 (87.1%) were initiated in the NH as opposed to 61 (8.3%) in the outpatient clinic and 34 (4.6%) in the ED. Inappropriate antibiotic prescribing for urinary tract infections differed significantly by setting: NHs (55.9%), ED (73.3%), and outpatient clinic (80.8%), P = .023. Regardless of infection type, patients who had an antibiotic initiated in an outpatient clinic had 2.98 (95% CI: 1.64–5.44, P < .001) times increased odds of inappropriate use. Conclusions: Antibiotics initiated out-of-facility for NH residents constitute a small but not trivial percent of all prescriptions and inappropriate use was high in these settings. Further research is needed to characterize antibiotic prescribing patterns for patients managed in these settings as this likely represents an important, yet under recognized, area of consideration in attempts to improve antibiotic stewardship in NHs.

7 August 2020 in Western Journal of Emergency Medicine
Verified
Journal Article
Open access
PDF file
MPMichael S. Pulia
Michael S. Pulia
IWIan Wolf
Ian Wolf
LSLucas T. Schulz
Lucas T. Schulz
APAurora Pop-Vicas
Aurora Pop-Vicas
RSRebecca Schwei
Rebecca Schwei
PLPeter K. Lindenauer
Peter K. Lindenauer
While current research efforts focus primarily on identifying patient level interventions that mitigate the direct impact of COVID-19, it is important to consider the collateral effects of COVID-19 on antimicrobial resistance. Early reports suggest high rates of antibiotic utilization in COVID-19 patients despite their lack of direct activity against viral pathogens. The ongoing pandemic is exacerbating known barriers to optimal antibiotic stewardship in the ED, representing an additional direct threat to patient safety and public health. There is an urgent need for research analyzing overall and COVID-19 specific antibiotic prescribing trends in the ED. Optimizing ED stewardship during COVID-19 will likely require a combination of traditional stewardship approaches (e.g. academic detailing, provider education, care pathways) and effective implementation of host response biomarkers and rapid COVID-19 diagnostics. Antibiotic stewardship interventions with demonstrated efficacy in mitigating the impact of COVID-19 on ED prescribing should be widely disseminated and inform the ongoing pandemic response.

8 January 2018 in Antimicrobial Resistance & Infection Control
Verified
Journal Article
Open access
PDF file
RRRobert Redwood
Robert Redwood
MKMary Jo Knobloch
Mary Jo Knobloch
DPDaniela C. Pellegrini
Daniela C. Pellegrini
MZMatthew J. Ziegler
Matthew J. Ziegler
MPMichael Pulia
Michael Pulia
NSNasia Safdar
Nasia Safdar
Background: Inappropriate ordering and acquisition of urine cultures leads to unnecessary treatment of asymptomatic bacteriuria (ASB). Treatment of ASB contributes to antimicrobial resistance particularly among hospital-acquired organisms. Our objective was to investigate urine culture ordering and collection practices among nurses to identify key system-level and human factor barriers and facilitators that affect optimal ordering and collection practices. Methods: We conducted two focus groups, one with ED nurses and the other with ICU nurses. Questions were developed using the Systems Engineering Initiative for Patient Safety (SEIPS) framework. We used iterative categorization (directed content analysis followed by summative content analysis) to code and analyze the data both deductively (using SEIPS domains) and inductively (emerging themes). Results: Factors affecting optimal urine ordering and collection included barriers at the person, process, and task levels. For ED nurses, barriers included patient factors, physician communication, reflex culture protocols, the electronic health record, urinary symptoms, and ED throughput. For ICU nurses, barriers included physician notification of urinalysis results, personal protective equipment, collection technique, patient body habitus, and Foley catheter issues. Conclusions: We identified multiple potential process barriers to nurse adherence with evidence-based recommendations for ordering and collecting urine cultures in the ICU and ED. A systems approach to identifying barriers and facilitators can be useful to design interventions for improving urine ordering and collection practices.